ranQ
ranQ
ranQ
DirectoryIndustriesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The first Swiss company directory, built to boost AI visibility.

Product
  • Pricing
  • Directory
  • Industries
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint742,806 companies indexed · Last updated: today
DirectoryIndustryMedical Technology IndustryZurichXeltis AG
Xeltis AG Logo
Verified· 2 sources

Xeltis AG

Summary

About the company

The core activity of Xeltis is the development and manufacturing of medical implants, particularly for the treatment of cardiovascular diseases, such as heart valves and vessels. The company focuses on developing innovative, bioresorbable materials and technologies to improve patient care in this field.

AI-generated
Offering

Products & services

Industry:Medical Technology Industry
✓ Offered5
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
Vascular implant for hemodialysis access (aXess™)
Vascular implant and access channel for hemodialysis, implanted in a procedure, with early possible cannulation and later conversion into a living vessel.
Endogenous Tissue Restoration (ETR) Platform
Bioresorbable supramolecular polymer platform that, through the body's own cell infiltration, generates living tissue and is replaced over time by its own vascular or valve tissue.
Coronary artery bypass conduit (XABG)
Restorative bypass connector for coronary heart disease, developed to maintain blood flow and to progressively form a long-term living vessel.
Pulmonary heart valve replacement (Xplore-2)
Restorative pulmonary heart valve intended to transform into a living valve made of patient-derived tissue, with an ongoing clinical study in Europe and the USA.
Clinical studies on vascular implants
Clinical programs and studies on aXess, XABG/CABG and Xplore-2 to assess safety, performance, patency and tissue transformation.

Knowledge

No knowledge articles yet

Once Xeltis AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

Xeltis AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Xeltis AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Xeltis AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Färberstrasse 6
8008 Zurich

At a glance

Legal form
Corporation
UID
CHE-113.004.605
Founded
2006 · 20 years
Last commercial register change
July 31, 2026
Employees
11 to 20

Similar companies

SF
Surgical Fusion Technologies GmbH
Schlieren
3S
3D Swiss-Dental Zürich GmbH
Zurich
BH
Baxter Healthcare SA
Glattpark (Opfikon)
EZ
Enamel Zahntechnische Manufaktur Kai Vogeler
Zurich